Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 4/20 | 0.51 |
| ▸ | CES2 | O00748 | 2/20 | 0.43 |
| ▸ | POLQ | O75417 | 8/20 | 0.43 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.36 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | RXRB | P28702 | 1/20 | 0.35 |
| ▸ | RXRG | P48443 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18243408 | 0.95 | DAO (0.52) | DAOCES2POLQCYSLTR2CYSLTR1 | |
| SCHEMBL18377965 | 0.87 | DAO (0.55) | DAOCES2POLQIDO1RXRA | |
| SCHEMBL4049679 | 0.83 | DAO (0.48) | DAOCES2POLQCYSLTR2CYSLTR1 | |
| SCHEMBL18242683 | 0.81 | DAO (0.49) | DAOCES2POLQIDO1 | |
| SCHEMBL3902853 | 0.81 | DAO (0.49) | DAOCES2POLQIDO1 | |
| SCHEMBL18243157 | 0.80 | DAO (0.34) | DAO | |
| SCHEMBL29172379 | 0.80 | CYSLTR2 (0.51) | DAOCES2POLQCYSLTR2CYSLTR1 | |
| SCHEMBL3278364 | 0.80 | CES2 (0.50) | DAOCES2POLQIDO1RXRA | |
| SCHEMBL18242232 | 0.78 | DAO (0.33) | DAO | |
| SCHEMBL18242653 | 0.77 | GPR17 (0.36) | DAOCES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-10-22 | — | — | US | disclosed |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2016-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | CBR1, HAO2, CBR3 | DAO 24/4885CES2 1419/4885POLQ 1437/4885 |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | CBR1, HAO2, CBR3 | DAO 24/4885CES2 1419/4885POLQ 1437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.